Consequently, FXR represents a promising target for the treatment of metabolic disorders, showing beneficial effects in different diseases such as cholestasis, nonalcoholic steatohepatitis (NASH), obesity, and liver fibrosis. Here, NR1H4 is linked to metabolic disease.